Lethality by pneumonia and factors associated to death  by Ferreira, Sidnei et al.
JO
L
S
M
a
b
R
A
d
R
0
h Pediatr (Rio J). 2014;90(1):92--97
www.jped.com.br
RIGINAL ARTICLE
ethality  by  pneumonia  and  factors  associated  to death,
idnei Ferreiraa,∗, Clemax C. Sant’Annaa, Maria de Fátima B.P. Marcha,
arilene  Augusta R.C. Santosb, Antonio Jose Ledo A. Cunhaa
Department  of  Pediatrics,  Faculdade  de  Medicina,  Universidade  Federal  do  Rio  de  Janeiro,  Rio  de  Janeiro,  RJ,  Brazil
Municipal  Health  Secretariat,  Rio  de  Janeiro,  RJ,  Brazil
eceived  21  February  2013;  accepted  15  May  2013
vailable  online  22  October  2013
KEYWORDS
Pneumococcal
pneumonia;
Penicillin  G;
Case-fatality  rate;
Inpatients;
Pediatric hospitals
Abstract
Objective:  to  describe  the  case-fatality  rate  (CFR)  and  risk  factors  of  death  in  children  with
community-acquired acute  pneumonia  (CAP)  in  a  pediatric  university  hospital.
Method: a  longitudinal  study  was  developed  with  prospective  data  collected  from  1996  to  2011.
Patients  aged  1  month  to  12  years  were  included  in  the  study.  Those  who  left  the  hospital  against
medical  orders  and  those  transferred  to  ICU  or  other  units  were  excluded.  Demographic  and
clinical-etiological  characteristics  and  the  initial  treatment  were  studied.  Variables  associated
to  death  were  determined  by  bivariate  and  multivariate  analysis  using  logistic  regression.
Results: a  total  of  871  patients  were  selected,  of  whom  11  were  excluded;  thus  860  children
were included  in  the  study.  There  were  26  deaths,  with  a  CFR  of  3%;  in  58.7%  of  these,  penicillin
G  was  the  initial  treatment.  Pneumococcus  was  the  most  common  pathogen  (50.4%).  From  1996
to  2000,  there  were  24  deaths  (93%),  with  a  CFR  of  5.8%  (24/413).  From  2001  to  2011,  the  age
group  of  hospitalized  patients  was  older  (p  =  0.03),  and  the  number  of  deaths  (p  =  0.02)  and  the
percentage  of  disease  severity  were  lower  (p  =  0.06).  Only  disease  severity  remained  associated
to  death  in  the  multivariate  analysis  (OR  =  3.2;  95%CI:  1.2-8.9;  p  =  0.02).
Conclusion: when  the  1996-2000  and  2001-2011  periods  were  compared,  a  signiﬁcant  reduction
in CFR  was  observed  in  the  latter,  as  well  as  a  change  in  the  clinical  proﬁle  of  the  pediatric
inpatients  at  the  institute.  These  ﬁndings  may  be  related  to  the  improvement  in  the  socio-
economical status  of  the  population.  Penicillin  use  did  not  inﬂuence  CFR.
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Letalidade  por  pneumonia  e  fatores  associados  ao  óbito
Resumo
Objetivo:  descrever  a  taxa  de  letalidade  (TL)  e  os  fatores  de  risco  de  óbito  em  crianc¸as  com
pneumonia grave  adquirida  na  comunidade  (CAP)  em  um  hospital  universitário  pediátrico.
Método: foi  desenvolvido  um  estudo  longitudinal  com  dados  prospectivos  coletados  de  1996  a
2011.  Foram  incluídos  no  estudo  pacientes  com  idade  entre  1  mês  e  12  anos  de  idade.  Foram
excluídos aqueles  que  deixaram  o  hospital  desconsiderando  as  recomendac¸ões  médicas  e  aque-
les  transferidos  para  UTI  ou  outras  unidades.  Foram  estudadas  as  características  demográﬁcas,
clínicas e  etiológicas  e  o  tratamento  inicial.  As  variáveis  associadas  a  óbito  foram  determinadas
por  análise  bivariada  e  multivariada  utilizando  regressão  logística.
Resultados:  foi  selecionado  um  total  de  871  pacientes,  dos  quais  11  foram  excluídos;  assim,
foram incluídas  no  estudo  860  crianc¸as.  Houve  26  óbitos,  com  uma  TL  de  3%;  em  58,7%  desses,
penicilina  G  foi  o  tratamento  inicial.  Pneumococo  foi  o  patógeno  mais  comum  (50,4%).  De  1996
a  2000,  houve  24  óbitos  (93%),  com  uma  TL  de  5,8%  (24/413).  De  2001  a  2011,  a  faixa  etária  de
pacientes  internados  foi  mais  velha  (p  =  0,03)  e  o  número  de  óbitos  (p  =  0,02)  e  o  percentual
de gravidade  das  doenc¸as  foram  menores  (p  =  0,06).  Apenas  a  gravidade  das  doenc¸as  continuou
associada a  óbito  na  análise  multivariada  (RC  =  3,2;  IC  de  95%:  1,2-8,9;  p  =  0,02).
Conclusão: quando  os  períodos  de  1996-2000  e  2001-2011  foram  comparados,  foi  observada
uma reduc¸ão  signiﬁcativa  na  TL  no  último  período,  bem  como  uma  alterac¸ão  no  perﬁl  clínico
dos  pacientes  hospitalizados  no  instituto.  Esses  achados  podem  estar  relacionados  à  melhora
na  situac¸ão  socioeconômica  da  populac¸ão.  O  uso  de  penicilina  não  inﬂuenciou  a  TL.
© 2013  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
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Este é um artigo Open Access sob a licença de CC BY-NC-NDIntroduction
Community-acquired  pneumonia  (CAP)  remains  the  lead-
ing cause  of  death  in  children  worldwide,  contributing  to
approximately 14%  of  deaths  in  children  from  1  month  to  5
years of  age.  It  is  a  critical  illness  for  countries  to  achieve
part IV  of  the  Millennium  Development  Goals:  reduce  by  two
thirds the  mortality  rate  among  children  aged  <  5  years  from
1990 to  2015.1
Most  children  aged  <  5  years  have  four  to  six  acute  respi-
ratory infections  (ARIs)  per  year;  2%  to  3%  of  ARIs  develop
into CAP.2,3
Although  mortality  and  morbidity  rates  due  to  CAP  in  chil-
dren aged  <  5  years  have  been  decreasing  worldwide,  in
developing countries  the  mortality  is  still  a  serious  public
health problem,  with  approximately  1.2  million  deaths  per
year. According  to  the  World  Health  Organization  (WHO),
between 2001  and  2003,  20%  of  deaths  among  children
aged <  5  years  in  developing  countries  were  caused  by
CAP. According  to  Health  Informatics  Department  (DATASUS),
there was  a  signiﬁcant  reduction  in  mortality  from  CAP  in
children aged  <  5  years  in  the  period  1991-2007  in  Brazil. 2--6
However,  in  spite  of  this  reduction,  most  hospitalizations  for
pneumonia in  Brazil  are  of  children  aged  <  5  years  and  the
elderly.
Pneumococcus is  the  main  etiological  agent  of  CAP  in  chil-
dren aged  <  5  years  in  developing  and  developed  countries.
The most  commonly  isolated  etiological  agents  in  chil-
dren with  CAP  in  developing  countries  are:  Streptococcus
pneumoniae, Haemophilus  inﬂuenzae,  and  Staphylococ-
cus aureus.7--10In  most  CAP  cases  requiring  hospitalization,
treatment involves  the  choice  of  antibiotic  therapy  and
supportive care:  oxygen  therapy,  adequate  hydration,  and
W
m
m
wutrition.  As  it  is  usually  difﬁcult  to  identify  the  causative
gent, the  start  of  antibiotic  therapy  is  empirical  and  the
hoice is  based  on  personal  experience  or  previous  studies  on
he etiology  of  CAP.7,8,11--14This  study  aimed  to  describe  the
ase-fatality rate  (CFR),  the  clinical-etiological  proﬁle,  the
nitial treatment  with  antibiotics,  and  the  factors  associated
ith death  in  children  admitted  to  a  university  pediatric  hos-
ital with  CAP  from  1996  to  2011.  The  current  knowledge
n this  subject  is  limited,  and  the  results  will  contribute  to
mproving the  care  of  children  with  this  disease.
ethods
his  was  a  longitudinal,  hospital-based  observational  study,
ith prospective  data  collection  from  January  of  1996  to
ecember of  2011  at  the  Instituto  de  Puericultura  e  Pedia-
ria Martagão  Gesteira  (IPPMG)  of  the  Universidade  Federal
o Rio  de  Janeiro  (UFRJ),  Rio  de  Janeiro,  Brazil.  IPPMG  is
he only  university  hospital  that  treats  exclusively  pediatric
atients from  Rio  de  Janeiro,  and  it  is  a  referral  institu-
ion in  the  city  of  Rio  de  Janeiro.  It  offers  free  emergency
ervice, 900  consultations/month,  pediatric  intensive  care
nit (PICU,  since  September  of  2007),  wards,  approximately
,000 admissions/year,  and  outpatient  pediatric  service,
ith approximately  3,200  consultations/month.
Patients  aged  between  1  month  and  12  years  of  age,
ospitalized in  IPPMG  due  to  severe  CAP,  were  included
egardless of  the  presence  of  wheezing,  according  to  the
HO classiﬁcation.14 Patients  who  were  discharged  against
edical advice,  transferred  to  other  health  facilities,  or
ore recently  to  the  PICU,  or  patients  whose  data  records
ere incomplete  were  excluded.
9 Ferreira  S  et  al.
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Table  1  Case-fatality  rate,  clinical  proﬁle,  and  initial
treatment with  antibiotics  of  860  children  hospitalized  with
community-acquired  pneumonia  from  1996  to  2011.  Instituto
de  Puericultura  e  Pediatria  Martagão  Gesteira  (IPPMG)  of
the  Universidade  Federal  do  Rio  de  Janeiro  (UFRJ),  Rio  de
Janeiro,  Brazil  2012.
Variable n  %
Age  (years)  <  1  269  31.3
1 to  4  386  44.9
≥ 5 205 23.8
Gender Male  473  55.0
Female 387  45.0
Severe malnutrition Yes 72  8.4
No  788  91.6
Time of  hospitalization  (days)  0  to  6  160  18.6
7 to  14 464 54.0
>14 236  27.4
Initial treatment Penicillin 505  58.7
Others 355  41.3
Severe disease Yes 62  7.3
No  788  92.7
Comorbidity Yes 521 61.2
No 330  38.8
Pleural effusion Yes 232 27.2
No 622  72.8
Death Yes  26  3.0
No  834  97.0
m
R
A
d
a
t
a
2
w
c
w
i
w
t
s
2
c
F
t
t4  
All  children  had  one  or  more  of  the  following  signs
nd symptoms  associated  with  radiological  condensation
bnormalities: cough,  high  respiratory  rate,  sub  costal
epression, cyanosis,  ﬂaring  of  the  nostrils,  moaning,  irri-
ability/lethargy, torpor,  and  shock.  The  variable  of  interest
as death  (mortality)  in  relation  to  the  type  of  antibiotic
sed in  the  treatment.  The  following  variables  were  stud-
ed: age  (younger  than  1  year,  between  1  and  5  years,
nd 5  years  or  older;  also  categorized  as  as  younger
han ﬁve  years  or  ﬁve  years  and  older);  gender;  hospi-
alization time  (categorized  as  less  than  14  days  or  14
ays or  more;  or  as  zero  to  six,  seven  to  14,  and  more
han 14  days);  severe  illness  at  admission  (presence  of
t least  one  of  the  following  ﬁndings  concomitant  with
AP classiﬁed  as  severe  according  to  the  WHO  crite-
ia: signs  of  sepsis,  respiratory  failure,  cyanosis,  ﬂaring
f the  nostrils,  moaning,  torpor/coma,  irritability/torpor,
r shock);8,14 initial  treatment  with  antibiotics  (penicillin
r others);nutritional  status,  which  considered  the  2002
eight/age criterion  of  the  Brazilian  Ministry  of  Health15
o  classify  the  child  as  malnourished  (underweight  or
ery low  weight  for  age)  and  normal  weight;  comorbidity
present when  the  child  had  any  concomitant  disease,  usu-
lly chronic,  undergoing  treatment  at  the  IPPMG,  such  as:
heezing, persistent  asthma,  recurrent  pneumonia,  chronic
neumonia,  bronchopulmonary  dysplasia,  diabetes,  sickle
ell anemia,  AIDS,  systemic  rheumatoid  arthritis,  genetic
yndrome, encephalopathy,  heart  disease,  among  other
hronic diseases  and  associations  between  them);  pleural
ffusion (radiographic  evidence);  and  type  of  agent  (isolated
rom the  analysis  of  material  assessed  for  direct  examination
nd culture  sputum,  blood,  pleural  ﬂuid,  bronchoalveolar
ash/aspirate).
Chest X-rays  were  analyzed  by  a  radiologist  at  the  insti-
ution, adopting  the  standard  proposed  by  the  WHO.16
Data  were  collected  systematically,  daily,  from  the
rst day  of  admission  to  hospital  discharge,  by  post-
raduate students  of  the  Department  of  Pediatric  Pul-
onology of  the  IPPMG,  trained  for  such  assignment
nd under  the  supervision  of  professors  of  the  service.
he forms  prepared  for  this  purpose  were  previously
ested and  periodically  compared  with  data  from  medi-
al records,  by  researchers  other  than  those  responsible
or the  original  collection.  The  protocol  and  data  col-
ection system  were  implemented  and  tested  in  a  pilot
roject.
Data were  transferred  to  an  electronic  database  and  ana-
yzed using  Stata  software,  release  7.0.  Descriptive  analysis
as performed  for  the  entire  period,  generating  frequency
istributions of  the  selected  variables.  Then  the  bivari-
te analysis  was  performed,  with  death  as  the  outcome.
ariables associated  with  death  (p  <  0.05)  in  the  bivariate
nalysis were  submitted  to  multivariate  analysis  using  logis-
ic regression.  Odds  ratios  (ORs)  were  used  as  the  measure
f association,  with  a  95%  conﬁdence  interval,  and  the  chi-
quared test  was  used  for  statistical  inference;  signiﬁcance
as set  at  p  <  0.05.
Since most  deaths  occurred  in  the  period  of  1996-2000,t was  decided  to  compare  the  two  periods  (1996-2000  and
001-2011) in  relation  to  mortality,  clinical  proﬁle,  and  ini-
ial treatment,  and  to  analyze  the  factors  associated  with
eath in  the  ﬁrst  period.
i
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tIsolated etiological  agent  Yes  139  18.6
No 607  81.4
The  project  was  approved  by  the  Research  Ethics  Com-
ittee of  IPPMG.
esults
 total  of  871  children  were  studied;  nine  were  excluded
ue to  transfer  to  another  health  facility,  one  due  to  to  PICU
dmission, and  one  due  to  discharge  against  medical  advice,
otaling 860  children.  The  clinical  proﬁle,  initial  therapy,
nd CFR  of  these  children  are  shown  in  Table  1.  There  were
6 deaths,  with  a  total  CFR  of  3%.
Of  the  860  children  studied,  58.7%  were  initially  treated
ith penicillin  G.  Pneumococcus  was  the  isolated  etiologi-
al agent  in  50.4%  of  cases  (70/139),  including  in  pneumonia
ith pleural  effusion,  followed  by  Staphylococcus  aureus
n 11.5%  (16/139).  In  the  period  between  1996-2000,  there
ere 24  deaths  (93%  of  total),  with  a  CFR  of  5.8%  (24/413).
From  1996  to  2000,  there  were  413  hospitalizations;  in
he ten  following  years,  447.  The  mean  number  of  admis-
ions/year from  1996  to  2000  was  103,  and  from  2001  to
011, 45.  The  clinical  proﬁle,  initial  therapy,  and  CFR  in
hildren hospitalized  in  both  periods  are  shown  in  Table  2.
rom 2001  to  2011,  the  mean  age  was  higher  (p  =  0:03)  and
he number  of  deaths  was  lower  (p  =  0.02)  when  compared
o the  ﬁrst  period.  The  percentage  of  severity  was  higher
n the  ﬁrst  period  (10.6  to  4.1),  but  the  difference  was  not
tatistically signiﬁcant  (p  =  0.06).
In  the  bivariate  analysis,  the  following  variables  were  sta-
istically associated  with  death:  presence  of  malnutrition,
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Table  2  Case  fatality  rate,  clinical  proﬁle,  and  initial  treatment  with  antibiotics  of  860  children  hospitalized  with  community-
acquired  pneumonia.  1996-2000  and  2001-2011.  Instituto  de  Puericultura  e  Pediatria  Martagão  Gesteira  (IPPMG)  of  the
Universidade  Federal  do  Rio  de  Janeiro  (UFRJ),  Rio  de  Janeiro,  Brazil,  2012.
Variable  1996-2000  2001-2011
n  %  n  %  p
Age  (years) <  5 354  85.7 <  5 301  67.3  0.03
≥ 5  59  14.3  ≥  5  146  32.7
Gender  Male  238  57.6  Male  235  52.6  0.34
Female 175  42.4  Female  212  47.4
Severe malnutrition  Yes  35  8.5  Yes  38  9.1  0.90
No 378  91.5  No  378  90.9
Time of  hospitalization
(days)
<  14  255  61.7  <  14  369  82.6  0.16
≥ 14  158  38.3  ≥  14  78  17.4
Initial treatment  Penicillin  213  51.6  Penicillin  292  65.3  0.36
Others 200  48.4  Others  155  34.7
Severe disease  Yes  44  10.68  Yes  18  4.1  0.06
No 368  89.32  No  420  95.9
Comorbidity  Yes 281  68.00  Yes  249  55.7  0.09
No 132  32.00  No  198  44.3
Pleural effusion Yes 113  27.4  Yes  119  27.0  0.62
No 300  72.6 No  322  73.0
Death Yes 24  5.8  Yes  2  0.4  0.02
No 389  94.2 No  445  99.6
Isolated  etiological  agent Yes 67  20.0  Yes  72  17.3  0.48
8
wNo 263  
initial  treatment  with  antimicrobial  other  than  penicillin,
presence of  comorbidity,  and  presence  of  pleural  effusion
(Table 3).  As  most  of  these  variables  indicate  severity,  the
association between  them  and  the  variable  severe  illness
o
b
p
Table  3  Association  between  death  and  selected  variables  in  413
1996-2000.  Results  of  the  bivariate  analysis.  Instituto  de  Puericultu
Federal  do  Rio  de  Janeiro  (UFRJ),  Rio  de  Janeiro,  Brazil,  2012.
Variable  Death  Non-de
n  %  
Age  (years)  <  1  12  50  160  
1 to  4  10  42  172  
≥ 5  2  8  57  
Gender  Male  12  50  226  
Female 12  50  163  
Severe malnutrition  Yes  6  25  29  
No 18  75  360  
Time of  0  to  6  7  29  48  
hospitalization  7  to  14  5  21  195  
(days) >  14 12  50  146  
Initial treatment  Penicillin  6  25  207  
Others 18  75  182  
Severe disease  Yes  10  42  135  
No 14  58  254  
Comorbidity Yes  22  92  259  
No 2  8  130  
Pleural effusion  Yes  1  4  134  
No 23  96  255  
CI, conﬁdence interval.0.0 No  344  82.7
as  analyzed,  but  it  was  not  statistically  signiﬁcant.  It  was
bserved that  severe  disease  was  associated  with  comor-
idity (OR  =  17.8,  95%  CI:  12.0-26.3)  and  the  occurrence  of
leural effusion  (OR  =  4.6,  95%  CI:  2.7-6.0),  which  caused
 children  hospitalized  with  community-acquired  pneumonia,
ra  e  Pediatria  Martagão  Gesteira  (IPPMG)  of  the  Universidade
ath  Odds  ratio  95%  CI  p-value
%
41  2.1  0.4-14.2  0.25
44  1.6  0.3-11.3  0.40
15  1.0
58  0.7  0.2-1.7  0.5
42
7  4.1  1.3-12.3  0.01
93
12  1.0
50  0.1  0.05-0.6  0.04
38  0.5  0.1-1.6  0.18
53  0.2  0.1-0.8  0.01
47
35  1.3  0.5-3.3  0.63
65
67  5.5  1.2-34.9  0.01
33
34  0.08  0.0-0.4  0.02
66
96  
Table  4  Association  between  death  and  selected  varia-
bles in  413  children  hospitalized  with  community-acquired
pneumonia, 1996-2000.  Results  of  the  multivariate  analy-
sis. Instituto  de  Puericultura  e  Pediatria  Martagão  Gesteira
(IPPMG) of  the  Universidade  Federal  do  Rio  de  Janeiro
(UFRJ), Rio  de  Janeiro,  Brazil,  2012.
Death  Odds  ratioa 95%  CI  p-value
Initial  penicillin  0.4  1.0--0.1  0.07
Severe malnutrition  1.9  0.7--5.0  0.1
Comorbidity 1.8  0.3--8.7  0.4
Pleural effusion  0.1  0.02--1.2  0.08
Age in  months  0.9  0.9--1.0  0.4
Severe disease 3.2 1.2--8.9  0.02
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iCI, conﬁdence interval.
a Logistic regression.
his  variable  to  remain  in  the  multivariate  analysis,  in  addi-
ion to  others  associated  with  death  in  the  bivariate  analysis.
It  was  also  decided  to  maintain  the  variable  age  (in
onths), since  the  difference  in  risk  of  death  in  younger  chil-
ren has  been  proven.1 In  the  multivariate  analysis,  severe
isease was  the  only  single  variable  that  remained  signiﬁ-
antly associated  with  death  (Table  4).
iscussion
his  study,  conducted  in  a  university  pediatric  referral  cen-
er in  Rio  de  Janeiro  from  1996  to  2011,  showed  that  the
FR in  children  with  CAP  was  low  (3%),  and  that  the  disease
ffected mainly  children  younger  than  5  years  (76.2%)  ini-
ially treated  with  penicillin  (58.7%)  and  with  a  comorbidity
61.2%). However,  most  deaths  occurred  in  the  period  1996-
000 (93%),  with  a  CFR  of  5.8%  in  this  period,  when  a greater
umber of  hospitalizations  for  CAP,  higher  incidence  of  hos-
italization for  CAP  in  younger  children,  and  more  cases  of
evere disease  were  observed.
The  CFR  observed  in  the  study  period  can  be  considered
ow, especially  because  this  is  a  referral  center  for  chil-
ren with  severe  disease  and  comorbidities.  Recent  studies
erformed in  low-income  countries  have  shown  CFR  ranging
rom 5.8%  to  8.2%.1,17--19However,  considering  the  two  stud-
ed periods,  distinct  differences  in  proﬁle  can  be  observed,
oth in  CFR  and  in  age  and  severity  on  admission,  with  a
rend to  shorter  hospital  stay  and  lower  severity  on  admis-
ion in  the  second  period  (2001-2011),  raising  questions
egarding the  reason  for  this  difference.
Important  changes  occurred  in  Brazil  in  recent  years  that
ay partly  explain  this  proﬁle  change.  In  the  period  of  1997-
008, which  covers  most  of  the  present  study,  the  infant
ortality rate  (IMR)  of  the  country  decreased  from  31.9
o 17.56,  whereas  in  the  state  of  Rio  de  Janeiro  it  ranged
rom 24.0  to  14.31.  The  mortality  rate  in  children  younger
han 5  years  (MRY5)  in  the  period  of  2000  to  2008  ranged
rom 31.99  to  20.49  in  Brazil  and  from  22.54  to  16.72  in
he state  of  Rio  de  Janeiro.  The  increase  in  vaccination
overage achieved  rates  >  90%.20--22Additionally,  a  trend  of
mprovement in  socioeconomic  status  was  observed  among
he parents,  as  demonstrated  by  the  decrease  in  unemploy-
ent rates,  reduction  of  illiteracy  rate  from  34%  in  the  1990s
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o  10%  in  2008,  and  of  the  poverty  rate  from  68%  in  1970
o 31%  in  2008,  on  account  of  social  programs  such  as  the
ncome distribution  program  of  the  Brazilian  government,
hich has  beneﬁted  over  10  million  Brazilians,  and  of  the
ncrease, with  real  gains,  in  the  minimum  wage.  The  Gini
ndex, which  measures  income  distribution,  showed  progres-
ive improvement  from  2003  to  2011,  whereas  in  the  same
eriod, the  percentage  of  population  in  poverty  decreased
rom 24.4%  to  10.2%.21
According  to  the  United  Nations  Children’s  Fund
UNICEF),20 CAP  is  a  disease  associated  with  poverty,  as
ell as  environmental  factors,  malnutrition,  and  difﬁculty
n accessing  the  local  health  system.  Many  deaths  would
e prevented  with  exclusive  breastfeeding,  adequate  nutri-
ion, vaccination,  washing  of  hands  with  soap  and  water,  and
vailability of  water  ﬁt  for  consumption  and  basic  sanitation
acilities. The  improvement  of  these  sanitation  conditions
n the  country,  due  to  the  improvement  in  socioeconomic
tatus, may  have  contributed  to  the  change  in  the  proﬁle
bserved in  hospitalizations  for  CAP  at  the  IPPMG.
Regarding  mortality,  the  presence  of  severity  on  admis-
ion was  the  only  single  variable  associated  with  death,
imilarly to  what  was  found  in  recent  studies  performed
n low-income  countries.17--20 The  abovementioned  demo-
raphic, epidemiological,  and  nutritional  transitions  were
ertainly  responsible  for  the  changes  in  morbidity  and  mor-
ality demonstrated  here.
Regarding  the  children  who  died  in  the  period  1996-2000,
2% had  severe  disease  and  92%  were  younger  than  5  years.
acterial isolation  was  achieved  in  62%,  showing  the  severity
f infection  with  hematogenous  dissemination  of  the  infec-
ion.
These ﬁndings  highlight  the  importance  of  severe  disease
n CFR  of  children  hospitalized  with  CAP,  and  suggest  that
t is  safe  to  start  treatment  with  penicillin  G.  This  ﬁnding  is
imilar to  that  found  by  the  multicenter  study  on  the  etiology
f CAP  and  penicillin  resistance  with  the  participation  of  sev-
ral countries  in  South  America  and  the  Caribbean,  including
he IPPMG.  In  that  study,  S.  pneumoniae  fully  resistant  to
enicillin was  not  found,  which  provided  support  to  the  rec-
mmendation of  penicillin  or  ampicillin  as  drugs  of  choice
or the  treatment  of  CAP,  even  for  penicillin-resistant  bacte-
ia, in  areas  where  the  minimum  inhibitory  concentration  is
ot higher  than  2  g/mL,  as  in  Brazil. 23
Similarly,  Simbalista  et  al., 24 in  a  retrospective  study  of
54 children  hospitalized  with  CAP  in  a  university  hospital
n Salvador,  Brazil,  from  2002  to  2005,  concluded  that  peni-
illin G,  used  to  treat  most  cases,  was  highly  effective,  with
mprovement within  the  ﬁrst  48  hours  and  no  occurrence  of
eaths.
One limitation  of  the  present  study  was  the  incapac-
ty to  assess  the  possible  impact  of  vaccination  status  on
he CFR  of  CAP  cases  studied.  As  the  conjugate  vaccination
gainst pneumococcal  agents  was  only  incorporated  into  the
mmunization schedule  of  Brazilian  children  in  2010,  such
nvestigation was  not  feasible.
In  conclusion,  the  present  study  demonstrated  a  signif-
cant reduction  in  CFR  in  children  with  CAP  in  the  period
001-2011, with  a  change  in  the  proﬁle  of  children  hospi-
alized for  this  disease  at  IPPMG.  It  is  suggested  that  these
ndings are  related  to  changes  in  the  socioeconomic  proﬁle
f the  population  in  this  period.25 The  use  of  penicillin  in  the
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empiric  treatment  of  CAP  was  not  related  to  the  observed
CFR.
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